Strategic Response to an Outbreak of Circulating Vaccine-Derived Poliovirus Type 2-Syria, 2017-2018

被引：22
|
作者：
Mbaeyi, Chukwuma [1 ]
Wadood, Zubair Mufti [2 ]
Moran, Thomas [2 ]
Ather, Fazal [3 ]
Stehling-Ariza, Tasha [4 ]
Nikulin, Joanna [2 ]
Al Safadi, Mohammad [2 ]
Iber, Jane [5 ]
Zomahoun, Laurel [1 ]
Abourshaid, Nidal [6 ]
Pang, Hong [5 ]
Collins, Nikki [5 ]
Asghar, Humayun [2 ]
Butt, Obaid ul Islam [2 ]
Burns, Cara C. [5 ]
Ehrhardt, Derek [1 ]
Sharaf, Magdi [2 ]
机构：
[1] CDC, Global Immunizat Div, Ctr Global Hlth, Atlanta, GA 30333 USA
[2] WHO, Polio Eradicat Dept, Geneva, Switzerland
[3] United Nations Childrens Fund, Middle East & North Africa Off, Amman, Jordan
[4] CDC, Div Global Hlth Protect, Ctr Global Hlth, Atlanta, GA 30333 USA
[5] CDC, Div Viral Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA
[6] United Nations Childrens Fund, Syria Country Off, Damascus, Syria
来源：
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT | 2018年 / 67卷 / 24期
关键词：
PROGRESS; ERADICATION; WORLDWIDE;
D O I：
10.15585/mmwr.mm6724a5
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
What is already known about this topic? Oral poliovirus vaccine (OPV) contains live attenuated viruses, which rarely revert to neurovirulence. These vaccine-derived polioviruses (VDPVs) tend to emerge in populations with low OPV coverage and are capable of causing paralysis. What is added by this report? In 2017, an outbreak of circulating VDPV type 2 (cVDPV2) occurred in Syria, causing 74 cases. Implementation of three rounds of monovalent OPV type 2 campaigns coupled with intensified surveillance interrupted the outbreak. What are the implications for public health practice? The outbreak in Syria underscores the risk for emergence of vaccine-derived polioviruses in settings of low OPV coverage. High-quality surveillance and targeted vaccination using monovalent OPV type 2 are effective in controlling cVDPV2 outbreaks. © 2018, Department of Health and Human Services. All Rights reserved.
引用
收藏
页码：690 / 694
页数：5
相关论文
共 50 条
  • [41] Monitoring the Risk of Type-2 Circulating Vaccine-Derived Poliovirus Emergence During Roll-Out of Type-2 Novel Oral Polio Vaccine
    Peak, Corey M.
    Lyons, Hil
    Voorman, Arend
    Gray, Elizabeth J.
    Cooper, Laura V.
    Blake, Isobel M.
    Hawes, Kaija M.
    Bandyopadhyay, Ananda S.
    VACCINES, 2024, 12 (12)
  • [42] The emergence of the circulating vaccine-derived poliovirus type 2 in multiple countries requires active surveillance: current scenario and counteracting strategies
    Mohapatra, Ranjan K.
    Kutikuppala, L. V. Simhachalam
    Seidel, Veronique
    Ansari, Azaj
    Mishra, Snehasish
    Kandi, Venkataramana
    INTERNATIONAL JOURNAL OF SURGERY, 2024, 110 (12) : 8167 - 8168
  • [43] Response to back-to-back outbreaks of circulating vaccine-derived poliovirus type 2 in two nomadic pastoralist settlements in Oti Region, Ghana-2019
    Donne Kofi Ameme
    Yaw Ofori Yeboah
    John Kofi Odoom
    Senanu Kwesi Djokoto
    Ernest Akyereko
    Abdulaziz Mamudu
    Mukaila Diwura
    William Opare
    Patrick Avevor
    Stanley Diamenu
    Sally-Ann Ohene
    Ernest Kenu
    Franklin Asiedu-Bekoe
    Archives of Public Health, 81
  • [44] Response to back-to-back outbreaks of circulating vaccine-derived poliovirus type 2 in two nomadic pastoralist settlements in Oti Region, Ghana-2019
    Ameme, Donne Kofi
    Yeboah, Yaw Ofori
    Odoom, John Kofi
    Djokoto, Senanu Kwesi
    Akyereko, Ernest
    Mamudu, Abdulaziz
    Diwura, Mukaila
    Opare, William
    Avevor, Patrick
    Diamenu, Stanley
    Ohene, Sally-Ann
    Kenu, Ernest
    Asiedu-Bekoe, Franklin
    ARCHIVES OF PUBLIC HEALTH, 2023, 81 (01)
  • [45] Isolation and Characterization of a Type 2 Vaccine-Derived Poliovirus from Environmental Surveillance in China, 2012
    Tao, Zexin
    Zhang, Yong
    Liu, Yao
    Xu, Aiqiang
    Lin, Xiaojuan
    Yoshida, Hiromu
    Xiong, Ping
    Zhu, Shuangli
    Wang, Suting
    Yan, Dongmei
    Song, Lizhi
    Wang, Haiyan
    Cui, Ning
    Xu, Wenbo
    PLOS ONE, 2013, 8 (12):
  • [46] Global Impact of Mass Vaccination Campaigns on Circulating Type 2 Vaccine-Derived Poliovirus Outbreaks: An Interrupted Time-Series Analysis
    Cooper, Laura, V
    Bandyopadhyay, Ananda S.
    Grassly, Nicholas C.
    Gray, Elizabeth J.
    Voorman, Arie
    Zipursky, Simona
    Blake, Isobel M.
    JOURNAL OF INFECTIOUS DISEASES, 2025, 231 (02): : e446 - e455
  • [47] Real-time monitoring of a circulating vaccine-derived poliovirus outbreak immunization campaign using digital health technologies in South Sudan
    Bello, Isah Mohammed
    Sylvester, Maleghemi
    Ferede, Melesachew
    Akpan, Godwin Ubong
    Ayesheshem, Ademe Tegegne
    Mwanza, Michael Nzioki
    Okiror, Samuel
    Anyuon, Atem
    Oluseun, Olu Olushayo
    PAN AFRICAN MEDICAL JOURNAL, 2021, 40
  • [48] Implication of a High Risk for Type 2 Vaccine-Derived Poliovirus Emergence and Transmission After the Switch From Trivalent to Bivalent Oral Poliovirus Vaccine
    Yan, Dongmei
    Wang, Dongyan
    Zhang, Yong
    Li, Xiaolei
    Tang, Haishu
    Guan, Jing
    Song, Yang
    Zhu, Shuangli
    Xu, Wenbo
    JOURNAL OF INFECTIOUS DISEASES, 2021, 223 (01): : 113 - 118
  • [49] Editorial from guest editors for Vaccine supplement: Vaccine-derived poliovirus type 2 outbreaks after the cessation of use of oral poliovirus vaccine type 2-2016-2021
    Wonodi, Chizoba
    Moss, William J.
    VACCINE, 2023, 41 : A1 - A1
  • [50] Detection of vaccine-derived poliovirus type 2 from sewage samples and public health response, Poland, November to December 2024
    Wieczorek, Magdalena
    Gad, Beata
    Krzysztoszek, Arleta
    Klosiewicz, Paulina
    Oleksiak, Kinga
    Zaborski, Bartosz
    Grzesiowski, Pawel
    Tkaczuk, Katarzyna
    Baumann-Popczyk, Anna
    EUROSURVEILLANCE, 2025, 30 (01)
12345